Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-19

Clinical Trial Update: Sanofi Pasteur's Tdap Combined Vaccine as a Booster Versus Local DT Vaccine in Children or Versus Local Td Vaccine in Adolescents and Adults in China. [Phase 3]

View source ↗

Summary

Phase 3 trial in China evaluating Sanofi Pasteur's Tdap booster vaccine against local diphtheria-tetanus vaccines in children and adolescents/adults; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diphtheria-Tetanus (DT) Vaccine (Diphtheria-Tetanus vaccine)
  • Tdap Combined Vaccine (Tdap vaccine)
  • Tetanus-Diphtheria (Td) Vaccine (Tetanus-Diphtheria vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Diphtheria, Tetanus | Phase 3 | Status: COMPLETED